Isolation of a New Human Retrovirus from West African Patients with AIDS

Abstract

The etiological agent of AIDS, LAV/HTLV-III, is common in Central Africa but is not endemic in other areas of that continent. A novel human retrovirus, distinct from LAV/HTLV-III, has now been isolated from two AIDS patients from West Africa. Partial characterization of this virus revealed that it has biological and morphological properties very similar to LAV but that it differs in some of its antigenic components. Although the core antigens may share some common epitopes, the West African AIDS retrovirus and LAV differ substantially in their envelope glycoproteins. The envelope antigen of the West African virus can be recognized by serum from a macaque with simian AIDS infected by the simian retrovirus termed STLV-IIImac, suggesting that the West African AIDS virus may be more closely related to this simian virus than to LAV. Hybridization experiments with LAV subgenomic probes further established that this new retrovirus, here referred to as LAV-II, is distantly related to LAV and distinct from STLV-IIImac.

Multibranched V3 peptides inhibit human immunodeficiency virus infection in human lymphocytes and macrophages

“…Amino Viruses. Laboratory strains HIV-1(LAI) (2), HIV-1(NDK) (34), and HIV-2(ROD) (8) were produced in CEM cells. Macrophage-tropic HIV-1(89.6) (9) was produced in CEMx174 cells as previously described (35).…”

A possible role for cysteine residues in the fidelity of DNA synthesis exhibited by the reverse transcriptases of human immunodeficiency viruses type 1 and type 2

“…Human immunodeficiency viruses type 1 and 2 represent a distinct group of lentiviruses associated with acquired immunodeficiency syndrome (AIDS) [1,2], An important characteristic of HIV-1 and HIV-2 is their high genomic diversity 1" [3][4][5]. It has been suggested that much of this genetic heterogeneity stems from the low fidelity of the reverse transcription step [6].…”

Viral surface glycoproteins, gp120 and gp41, as potential drug targets against HIV-1: Brief overview one quarter of a century past the approval of zidovudine, the first anti-retroviral drug

“…Worldwide, the predominant virus is HIV-1, and generally when people refer to HIV without specifying the type of virus they will be referring to HIV-1. The relatively uncommon HIV-2 type is concentrated in West Africa and is rarely found elsewhere [8].…”